Toke of the Town

Search Results: patent license (11)

Cannabinoid Patent Exclusivity Only Applies To One Condition

0
By on Medical, News

Black Tie Magazine
Dean Petkanas, CEO, KannaLife: “Our exclusivity is narrowly focused”

​Exclusive Interview: Dean Petkanas, CEO, KannaLife

(The Company Just Awarded An Exclusive Cannabinoid License By The Federal Government)

The exclusive rights to apply the cannabinoids found in marijuana as therapeutic agents awarded by the U.S. federal government to the firm KannaLife only apply to one specific medical condition, KannaLife’s CEO told Toke of the Town Monday night.

Dean Petkanas, chief executive officer at KannaLife Sciences, told us that the exclusivity applies only for the development and sale of cannabinoid based therapeutics as antioxidants and neuroprotectants for use in the treatment of hepatic encephalopathy.
“It is narrowly defined exclusivity, in that field,” Petkanas told us. “Our exclusivity is narrowly focused.”
Asked if KannaLife planned to get exclusive rights to develop cannabinoids to treat other conditions, Petkanas answered, “At the present time, we have no desire to do that.”
Read More

Feds To Grant Exclusive Cannabinoid License To Pharma Firm

0
By on Legislation, Medical, Products

Medical Marijuana Hut

​The U.S. federal government’s Department of Health and Human Services seems about ready to award exclusive rights to apply marijuana as a medical therapeutic. You read that correctly: “exclusive rights.”

Now, I don’t think of myself as a conspiracy theorist. But when the federal government keeps taking actions that, even when considered separately but especially when viewed together, all seem to be part of a bigger plan to pave the way for the pharmaceutical industry to bulldoze the cottage medical marijuana industry, I start getting antsy.
“We find it hypocritical and incredible that on the one hand, the U.S. Department of Justice is persecuting cannabis patient associations, asserting that the federal government regards marijuana as having absolutely no medical value, despite overwhelming clinical evidence,” said Union of Medical Marijuana Patients director James Shaw. “On the other hand, the Department of Health and Human Services is planning to grant patent rights with possible worldwide application to develop medicine based on cannabis.”
“Though UMMP welcomes any potential new research that could come from KannaLife Sciences’ federal endorsement, it is highly disconcerting that the contemplated grant is an exclusive one,” the organization posted on its website.
Read More

Canadian Company Plans Massive Grow

0
By on News, Uncategorized
The announcement comes shortly after it raised millions of dollars.
Here’s your daily round up of pot news, excerpted from the newsletter WeedWeek.
Vancouver-based grower Aurora Cannabis is planning a giant 600,000 square-foot grow in Alberta. That’s the size of 10 football fields. Canadian grower Aphria inked a deal to supply an Australian company with MED.
At least two large Canadian producers consider the  new federal home grow rules  “a setback for the advancement of sound cannabis policy.”
The Commodities Futures Trading Commission approved the first exchange for trading hemp derivatives.

The Wolves of Weed Street Could Legalize Medical Marijuana on a National Level

0
By on News

Commons/Deerstock.


The Wolves of Wall Street may have paved their way to success and ultimately, a federal penitentiary by snorting copious amounts of cocaine and gang banging high-end prostitutes while running penny stock scams on blue-collar America, but these cash carnivores are preparing to sink their teeth into a new kind of green these days – legal marijuana.

Read More

Worth Repeating: Big Pharma Takeover Of Med Marijuana In 2013

0
By on Medical

Gaia Health

Worth Repeating

By Ron Marczyk, RN
OK, somebody please talk me off the ledge on this one…
It has already started… This is what a dying war on marijuana looks like.
The U.S. government is in an untenable position; the war on marijuana has failed completely, but the U.S. government also holds the sole medical marijuana patent ever granted, which proves that cannabinoids from cannabis are powerful medicines that can save thousands of lives annually and save the government billions of dollars in health costs, treating everything from cancer to neurological diseases. 
But after 75 years of misinformation and brainwashing the U.S. population, and the world, that marijuana is an evil drug that must be eliminated, how can it now do a 180 degree turn and sell marijuana as a medicine to the same population? The coming verbal somersaults will be amazing!
Read More

Corporation Aims To Co-Opt Medical Marijuana, Make Billions

0
By on Medical, Products

Health Freedom Alliance

​Crushed Beneath the Medicine Wheel
By Kassy Fatooh
In a scheme they think capable of making billions, a US corporation not only plans to market a delivery system for medicinal cannabis, but also hopes to cut out small time farmers and private growers by introducing prohibitive protocols through state health departments.
In the course of following the medical story of myalgic encephalomyelitis, I’ve learned things I wish I didn’t know about the big business of medicine, about government agencies charged with public health, and about Big Pharma’s vendetta against alternative healing practices.
Our pain is their payday. Today’s story is one of cold avarice.
The corporation is called MMDS: Medical Marijuana Delivery Systems LLC, marketing its medical cannabis delivery system through its “Medicine Wheel” subsidiary.  They hold this patent for the Tetracan transdermal patch: like Nicoderm, but it delivers cannabinoids instead of nicotine.
They advertise it as providing all the benefits of medical marijuana, without the “health-destroying smoke.”
Read More

Parole Board Agrees To Early Hearing; Mother Serving 8 Years For Pot

0
By on News

John Clanton/Tulsa World
Patricia Spottedcrow is serving eight years in an Oklahoma prison for selling $31 worth of marijuana to a police informant

​

A young Oklahoma mother of four who is serving an eight-year prison sentence on a first-time marijuana offense — for selling $31 worth of pot — has a chance at parole after the parole board unanimously agreed to hear her case early.

Patricia Spottedcrow, 26, is scheduled to appear on the Pardon and Parole Board’s docket between April 17 and 20 in Oklahoma City, reports Ginnie Graham at Tulsa World.
Read More

ACLU-CO At Odds With ACLU-WA Over Marijuana DUI?

0
By on Legislation, Medical

THC Finder

​The American Civil Liberties Union (ACLU) of Colorado has endorsed an initiative to legalize marijuana in that state — one which does not establish what some activists call an “illegitimate” DUIC (Driving Under the Influence of Cannabis) law. But the ACLU of Washington state, according to Seattle-based political activist Edward Agazarm, “still out of sync with voters and supporters, stumbles forward with fatally flawed Initiative 502.”

ACLU-WA has formed New Approach Washington (NAW), a political action committee with the stated goal of promoting I-502 to legalize, regulate and tax marijuana. “Unfortunately, many citizen initiatives — though well intentioned — are riddled with errors and mistakes,” Agazarm said in an email to Toke of the Town and other media outlets. “Initiative 502 is a prime example.”
“In what appears to be Washington’s latest initiative blunder, I-502 contains last-minute DUI language that, because of science, has already been rejected by state state Legislatures (Colorado and Oregon) and a state Supreme Court (Michigan),” Agazarm said.
Read More

Worth Repeating: DEA Faces Suit For Blocking Marijuana Research

0
By on Medical

Montana Biotech
U.S. federal government-issued cannabis

​Welcome to Room 420, where your instructor is Mr. Ron Marczyk and your subjects are wellness, disease prevention, self actualization, and chillin’.

Worth Repeating

​By Ron Marczyk, R.N.
Health Education Teacher (Retired)

DEA policy is a violation of the fundamental principles of the scientific method. Seventy-five years of bias must come to an end.
First, the backstory.
Jan 12, 2009:
“With one foot out the door, the Bush administration has once again found time to undermine scientific freedom,” said Allen Hopper, litigation director of the American Civil Liberties Union Drug Law Reform Project. “In stubbornly retaining the unique government monopoly over the supply of research marijuana over the objections of DEA’s own administrative law judge, the Bush administration has effectively blocked the proper regulatory channels that would allow the drug to become a wholly legitimate prescription medication.”
“The federal government’s official policy is that marijuana has no medical benefit.”
The American Civil Liberties Union said in a legal brief that the DEA’s politics are keeping 
cannabis-based medicines off shelves.
Read More

Worth Repeating: Medical Marijuana Is The Best Kept Secret

0
By on Medical

​​

Photo: Geoff Pugh/The Telegraph
Ben Whalley, middle, with Dr Gary Stephens and Dr Claire Williams of Reading University at a secret cannabis farm in the south of England in the hope of producing a new treatment for epilepsy

​Welcome to Room 420, where your instructor is Mr. Ron Marczyk and your subjects are wellness, disease prevention, self actualization, and chillin’.

​
Worth Repeating

​

By Ron Marczyk, R.N.

An overwhelming amount of very promising research has been gathered supporting the use of medical cannabis for many illnesses and diseases… and the evidence is now impossible to ignore.

Examples:
“The endogenous cannabinoid system has revealed potential avenues to treat many disease states … Medicinal indications of cannabinoid drugs including compounds that result in enhance endocannabinoid responses (EER) have expanded markedly in recent years.”
“The wide range of indications covers … chemotherapy complications, tumor growth, addiction, pain, multiple sclerosis, glaucoma, inflammation, eating disorders, age-related neurodegenerative disorders, as well as epileptic seizures, traumatic brain injury, cerebral ischemia, and other excitotoxic insults.”
Source: “Cannabinoid drugs and enhancement of endocannabinoid responses: strategies for a wide array of disease states,” Current Molecular Medicine, September 2006
Read More
1 2